TLR4 and colorectal carcinoma: It is safe at therapeutic doses and efficiently inhibits NF-κB, showing potent anti-tumor effects on CRC by suppressing cell viability, inducing apoptosis, and modulating the TLR4/NF-κB pathway [26].